Answers are grounded in this paper and cite their sources.
Our results specify the frequently reported "reduced diversity" of the AD-related skin microbiome to reduced Evenness, which was in turn mainly driven by S. aureus relative abundance, rather than to a reduced microbiome Richness. Finding associations between AD severity, the skin microbiome and patient's cofactors is a key aspect in developing new personalized AD treatments, particularly those targeting the AD microbiome.
No takes yet. Share an insight, caveat, or question.
Rauer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: